Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Langer currently holds 804,525 shares of Echo Therapeutics, Inc. (ECTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Langer has been a net seller of ECTE stock. They have purchased $25.0K and sold $2.8M worth of shares.
Robert Langer's most recent insider trade was on Jul 7, 2025, when they sold 20,500 shares at $0.00 per share.
Robert Langer serves as Executive at Echo Therapeutics, Inc. (ECTE). They have executed 95 insider transactions totaling $2.8M over their tenure at the company.
Robert Langer holds the position of Executive at Echo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert Langer has shown a selling trading pattern, with $25.0K in total purchases and $2.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert Langer was on Feb 10, 2016, when they sold $433.5K worth of OCAT shares. This transaction involved 51,000 shares at $8.50 per share.
Robert Langer currently owns 804,525 shares of Echo Therapeutics, Inc. (ECTE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Langer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Langer has 95 Form 4 filings on record as an insider at Echo Therapeutics, Inc..
Set alerts for Robert Langer and 40,000+ other insiders.